This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Alain Merschaert: Innovator in Asymmetric Synthesis
Introduction
Alain Merschaert is a notable inventor based in Mont Saint Guibert, Belgium. He has made significant contributions to the field of chemistry, particularly in the synthesis of pharmaceuticals. His work has led to advancements that benefit both the scientific community and the pharmaceutical industry.
Latest Patents
Merschaert holds a patent for a "Process for the asymmetric synthesis of duloxetine." This invention provides an improved asymmetric process for the synthesis of duloxetine involving arylation of Compounds of Formula I. His innovative approach enhances the efficiency and effectiveness of producing this important medication.
Career Highlights
Alain Merschaert is associated with Eli Lilly and Company, a leading global pharmaceutical company. His role at Eli Lilly has allowed him to work on groundbreaking projects that push the boundaries of medicinal chemistry. His expertise in asymmetric synthesis has positioned him as a valuable asset in the development of new therapeutic agents.
Collaborations
Merschaert has collaborated with esteemed colleagues, including Mark Anthony Butchko and Kenneth Philip Moder. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the field.
Conclusion
Alain Merschaert's contributions to the field of asymmetric synthesis exemplify the impact of innovative thinking in pharmaceutical development. His work continues to influence the industry and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile